TENX: Tenax Therapeutics, Inc.
Performance
TENX -74.68%
Watchlist
Select an item
Summary
TENX at a glance
TENX returned -74.68% over the past year and -76.43% a year over five years. Its worst drop in that year was -92.58%, smaller than 0% of stocks on Redstone, and its Sharpe ratio of 0.29 beats 40% of stocks on Redstone. It pays no dividends.
Current Drawdown
-90.28%
Rolling Volatility
100.15%
Actions
Metrics
Risk Indicators
Alpha26.04%
Beta1.12x
Sharpe0.29
Sortino0.36
Omega1.07
Calmar-0.81
Martin0.74
Profile
About TENX
Tenax Therapeutics Inc is a phase three, development-stage pharmaceutical company focused on identifying and developing therapeutics that address cardiovascular and pulmonary diseases with high unmet medical need, with an initial therapeutic focus on pulmonary hypertension.
- Sector
- Health Care
- Industry
- Pharmaceutical Preparations
- Market cap
- $67M
- Listed
- Feb 1995
- Employees
- 16
- Headquarters
- Chapel Hill, NC
- Website
- tenaxthera.com
Comparisons